CareDx, Inc. (CDNA) vs Veracyte, Inc. (VCYT)
- CareDx, Inc. CDNA 63.81 −4.30%
- Veracyte, Inc. VCYT 43.12 −2.86%
CareDx, Inc. and Veracyte, Inc. are both Diagnostics & Research companies. CareDx, Inc. and Veracyte, Inc. are of similar size ($3.6B and $3.5B). CareDx, Inc. trades at the lower P/E: 29.7× against 29.9×. CareDx, Inc. grew revenue faster over the last twelve months: 34.4% against 17.3%. CareDx, Inc. has the higher net margin (24.2% vs 20.4%) and the higher return on invested capital (130.1% vs 7.32%). Across the 20 metrics below, Veracyte, Inc. leads on 11 and CareDx, Inc. on 9.
Valuation
Profitability
| Metric | CDNA | VCYT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 70.58% | 71.71% | 50.89% |
| Operating margin | 23.61% | 18.82% | (8.57%) |
| Net margin | 24.23% | 20.37% | (6.37%) |
| Free cash flow margin | 18.49% | 29.54% | 0.00% |
| Return on equity | 29.49% | 8.77% | (2.92%) |
| Return on assets | 22.72% | 8.09% | (6.71%) |
| Return on invested capital | 130.06% | 7.32% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack